Novo Nordisk Aktie
41,37
EUR
+0,14
EUR
+0,33
%
41,20
EUR
-0,89
EUR
-2,11
%
Werbung
Novo Nordisk Aktie Analyse
| 08.08.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 02.08.16 | Novo Nordisk buy | Citigroup Corp. | |
| 01.08.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 27.07.16 | Novo Nordisk buy | Citigroup Corp. | |
| 25.07.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 13.07.16 | Novo Nordisk overweight | Morgan Stanley | |
| 13.07.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 29.06.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
|
Werbung
|
|||
| 23.06.16 | Novo Nordisk buy | Citigroup Corp. | |
| 15.06.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 14.06.16 | Novo Nordisk buy | Citigroup Corp. | |
| 14.06.16 | Novo Nordisk Conviction Buy | Goldman Sachs Group Inc. | |
| 13.06.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 09.06.16 | Novo Nordisk overweight | Morgan Stanley | |
| 09.06.16 | Novo Nordisk buy | Baader Wertpapierhandelsbank | |
| 26.05.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 26.05.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 23.05.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 04.05.16 | Novo Nordisk buy | Citigroup Corp. | |
| 03.05.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 02.05.16 | Novo Nordisk overweight | Barclays Capital | |
| 29.04.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 26.04.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 22.04.16 | Novo Nordisk overweight | Morgan Stanley | |
| 18.04.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 29.03.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 22.03.16 | Novo Nordisk overweight | Morgan Stanley | |
| 07.03.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 07.03.16 | Novo Nordisk overweight | Morgan Stanley | |
| 07.03.16 | Novo Nordisk buy | Citigroup Corp. | |
| 07.03.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 02.03.16 | Novo Nordisk buy | Citigroup Corp. | |
| 24.02.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.02.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 15.02.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.02.16 | Novo Nordisk overweight | Barclays Capital | |
| 04.02.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 01.02.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 01.02.16 | Novo Nordisk buy | Citigroup Corp. | |
| 01.02.16 | Novo Nordisk overweight | Morgan Stanley | |
| 01.02.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 26.01.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 21.01.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 08.01.16 | Novo Nordisk overweight | Barclays Capital | |
| 07.01.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 06.01.16 | Novo Nordisk overweight | Morgan Stanley | |
| 02.12.15 | Novo Nordisk overweight | Morgan Stanley | |
| 25.11.15 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 20.11.15 | Novo Nordisk buy | Citigroup Corp. | |
| 20.11.15 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
Werbung
Werbung